The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
0 pt

Opinion on  Biogen Idec Inc (BIIB)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Bullish on BIIB ...

Oct 11, 2008 12:37 AM UTC
Mikerun
Return Risk
+1.04% LOW
Principal

BIIB:  This call was made on 10/11/08 @ $43.98
Rating:   Positive   $43.98 (10/11/08)
Closed:   10/12/2008 @ $43.98 (+0.00% in 1 day)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +68.27% 211
3 stockmarketfunding.com 17.66 +25.61% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.42% 40


POPULAR STOCKS
Symbol Company Name Sentiment
DRYS DryShips Inc.
MSFT Microsoft Corp
IBM International Business Machines Corp
BIDU Baiducom Inc ADS
FNM Fannie Mae
BA The Boeing Company

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Biogen Idec Inc (BIIB)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
80.0%
Top:
66.5%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
DNDN Positive +0.07% 11/28/09
UNIFF N/A Positive n/a 11/28/09
CLDA N/A Positive +7.71% 11/26/09
PBIO N/A Positive -9.25% 11/24/09
PUMD N/A Positive n/a 11/23/09

View All >
   
Mike Havrilla previously rated BIIB
Positive +6.78% FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel
07/08/2009
9
Positive -12.22% FDA Decision Calendar: Pain Drug Delays Likely
02/10/2009
9
Positive +29.15% Biogen Reports Another PML Case in Tysabri Patient
10/30/2008
9
Positive +0.00% Biogen Reports Another PML Case in Tysabri Patient
10/29/2008
9
Positive -3.42% Biotech Blues: Four Stocks on Sale with Hope
10/25/2008
9
Positive -6.30% Who's Next in the Biotech Buyout Frenzy?
10/13/2008
9
Positive +0.00% An Even Pfatter Yield at Pfizer
10/12/2008
9
Positive -9.49% Clarity on Tysabri Makes Elan and Biogen a Buy
09/06/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch